Journal of Biopharmaceutical Statistics · 2017 · 24 citations · 16 references
PharmacyBiostatisticsClinical EpidemiologyEpidemiologic MethodsEpidemiologyPost-market SurveillancePost-marketing Safety SurveillancePostmarket SurveillancePostmarketing SurveillanceVaccine Safety SurveillanceLogistic RegressionPost-market Safety MonitoringPost-market Safety SurveillancePost-marketing Vaccine Safety MonitoringSafety Signal DetectionSurveillance SystemsVaccine Safety Signal DetectionVaccine-associated Adverse Event
The Vaccine Adverse Event Reporting System (VAERS) and other product surveillance systems compile reports of product-associated adverse events (AEs), and these reports may include a wide range of information including age, gender, and concomitant vaccines. Controlling for possible confounding variables such as these is an important task when utilizing surveillance systems to monitor post-market product safety. A common method for handling possible confounders is to compare observed product-AE combinations with adjusted baseline frequencies where the adjustments are made by stratifying on observable characteristics. Though approaches such as these have proven to be useful, in this article we propose a more flexible logistic regression approach which allows for covariates of all types rather than relying solely on stratification. Indeed, a main advantage of our approach is that the general regression framework provides flexibility to incorporate additional information such as demographic factors and concomitant vaccines. As part of our covariate-adjusted method, we outline a procedure for signal detection that accounts for multiple comparisons and controls the overall Type 1 error rate. To demonstrate the effectiveness of our approach, we illustrate our method with an example involving febrile convulsion, and we further evaluate its performance in a series of simulation studies.
16
Multiple Imputation after 18+ Years
Donald B. Rubin · Journal of the American Statistical Association · 1996 · 2.9K citations